Literature DB >> 22769979

A haemoperitoneum does not indicate active bleeding in the peritoneum in 50% of hypotensive blunt trauma patients: a study of 110 severe trauma patients.

J Charbit1, I Millet, K Lakhal, G Brault-Noble, F Guillon, P Taourel, X Capdevila.   

Abstract

BACKGROUND: We hypothesised that in blunt trauma patients with haemodynamic instability and haemoperitoneum on hospital admission, the haemorrhagic source may not be confined to the peritoneum. The purpose of this study was to describe the incidence and location of bleeding source in this population.
METHODS: The charts of trauma patients admitted consecutively between January 2005 and January 2010 to our level I Regional Trauma Centre were reviewed retrospectively. All hypotensive patients presenting a haemoperitoneum on admission were included. Hypotension was defined by a systolic blood pressure ≤ 90 mmHg. The haemoperitoneum was quantified on CT images or from operative reports as moderate (Federle score<3 or between 200 and 500 ml) or large (Federle score ≥ 3 or >500 ml). Active bleeding (AB) was defined as injury requiring a surgical or radiologic haemostatic procedure, regardless of origin (peritoneal (PAB) or extraperitoneal (EPAB)).
RESULTS: Of 1079 patients admitted for severe trauma, 110 patients met the inclusion criteria. Seventy-eight (71%) were male, mean age 35.3 (SD 19) years and mean ISS 36.5 (SD 20.5). Among the 91 patients who had AB, 37 patients (41%) had PAB, 34 (37%) had EPAB and 20 had both (22%). Forty-eight (53%) of them had moderate haemoperitoneum and 43 (47%) had large haemoperitoneum. A large haemoperitoneum had positive predictive value for PAB of 88% (95% CI 75-95%) and negative predictive value of 65% (95% CI 49-79%). The corresponding values in the subgroup of patients with EPAB were 65% (95% CI 38-86%) and 76% (95% CI 59-88%).
CONCLUSION: Haemoperitoneum was associated with PAB in only 52% of hypotensive blunt trauma patients and 63% of bleeding patients. In contrast, 59% of bleeding patients had at least one EPAB. The screening of a haemoperitoneum as a marker of active haemorrhagic source may be confusing and lead to misdiagnosis and inappropriate strategy. Clinician should exclude carefully the presence of any EPAB explaining haemorrhagic shock, before to decide haemostatic treatment.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blunt abdominal trauma; CT; Haemoperitoneum; Haemorrhagic shock; Management of trauma patients

Mesh:

Substances:

Year:  2012        PMID: 22769979     DOI: 10.1016/j.injury.2012.05.018

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  A simple CT score to quantify pelvic and retroperitoneal hematoma associated with pelvic fractures predicts transfusion needs, pelvic hemostatic procedures, and outcome.

Authors:  Jonathan Charbit; Severin Ramin; Margaux Hermida; Pierre Cavaille; Thibault Murez; Patrice Taourel; Xavier Capdevila; Ingrid Millet
Journal:  Emerg Radiol       Date:  2019-12-07

2.  Relationship between Obesity and Massive Transfusion Needs in Trauma Patients, and Validation of TASH Score in Obese Population: A Retrospective Study on 910 Trauma Patients.

Authors:  Audrey De Jong; Pauline Deras; Orianne Martinez; Pascal Latry; Samir Jaber; Xavier Capdevila; Jonathan Charbit
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

3.  How Does the Severity of Injury Vary between Motorcycle and Automobile Accident Victims Who Sustain High-Grade Blunt Hepatic and/or Splenic Injuries? Results of a Retrospective Analysis.

Authors:  Ting-Min Hsieh; Tsung-Cheng Tsai; Yueh-Wei Liu; Ching-Hua Hsieh
Journal:  Int J Environ Res Public Health       Date:  2016-07-21       Impact factor: 3.390

4.  Characteristics of computed tomography in hemodynamically unstable blunt trauma patients: Experience at a tertiary care center.

Authors:  Youn-Jung Kim; June-Sung Kim; Soo-Han Cho; Jun-Il Bae; Chang Hwan Sohn; Yoon-Seon Lee; Jae-Ho Lee; Kyoung-Soo Lim; Won Young Kim
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.